Skip to content

Dehydration Cognition

Impact of Dehydration and Rapid Rehydration on Cognitive Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05916183
Enrollment
15
Registered
2023-06-23
Start date
2023-07-05
Completion date
2023-12-22
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dehydration

Brief summary

The investigators want to understand the impact of the body losing and gaining water on brain function. Participants will restrict fluids consumed and exercise to lose 5% of body mass. Participants will then be provided fluid equal to the volume lost to consume over 2 hours (recovery). A series of brain function tests will be performed at baseline, following weight loss, and following recovery.

Detailed description

A baseline series of brain function tests will be performed. Following this, participants will complete a 24 hour fluid and water rich food restriction on the day proceeding testing. Participants will then complete moderate to high intensity exercise in a hot/humid room to achieve 5% body mass loss. Once baseline core body temperature returns to baseline levels, the series of brain function tests will be performed. Participants will then consume a sports drink equal to the volume of sweat lost over the course of a 2 hour recover period. Following this, he series of brain function tests will be performed.

Interventions

BEHAVIORALFluid loss and consumption

Upon 5% body mass loss, rehydration of fluid lost to sweating throughout a 2 hour recovery period

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 26 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Recreationally active * 18-26 years old

Exclusion criteria

* History of cardiovascular, metabolic, respiratory, neural, or renal disease * Hypertensive (systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg) or tachycardic (resting heart rate ≥ 100 bpm) during the screening visit * Taking medication or supplements with a known side effect of affecting physiological responses to exercise (e.g., aspirin, acetaminophen, beta blockers, statins, stimulants, depressants, SSRIs) * Tobacco or nicotine use in the past six months * Current or past musculoskeletal injury impacting physical activity * Study physician discretion based on any other medical condition or medication

Design outcomes

Primary

MeasureTime frameDescription
Multitasking testUpon completion of 5% body mass loss protocol, approximately 2 hours into the trialAccuracy score of a multitasking test (0-100%) with greater scores indicating a better outcome

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026